Vitamin K2 Extends Lifespan by Protecting Mitochondria in Worm Study
Low-dose Vitamin K2 activates a key longevity signaling pathway in C. elegans, reducing oxidative stress and extending lifespan.
Summary
Researchers at Dalian Medical University found that low-dose Vitamin K2 (5 micromolar) significantly extends lifespan in the roundworm C. elegans. The supplement improved mitochondrial health, reduced harmful reactive oxygen species, and protected the intestinal barrier. It worked by activating the JNK-1/SIR-2.1/DAF-16 signaling pathway — a well-known longevity axis — which in turn switched on protective genes including antioxidant enzymes and heat-shock proteins. Importantly, higher doses (10 micromolar) were toxic, highlighting that dosing matters. While these findings are in a simple organism, they provide a mechanistic foundation for exploring Vitamin K2 as a longevity-supporting supplement in more complex animals and eventually humans.
Detailed Summary
Vitamin K2 is already recognized for its roles in bone and cardiovascular health, but its potential as a longevity compound has received less attention. This study from Dalian Medical University investigates whether Vitamin K2 can extend lifespan and improve stress resistance, and if so, through what biological mechanisms.
The researchers used Caenorhabditis elegans, a transparent roundworm that is one of the most established model organisms in aging research. Worms were treated with varying concentrations of Vitamin K2 to identify optimal dosing, then subjected to a battery of functional, cellular, and molecular tests.
At 5 micromolar, Vitamin K2 extended worm lifespan, improved physiological function, protected the intestinal barrier, and reduced lipofuscin — a cellular waste product that accumulates with aging. Mitochondrial health improved markedly: mitochondrial morphology was preserved, reactive oxygen species (ROS) levels fell, and both mitochondrial membrane potential and ATP production increased. The mechanism centered on activation of the JNK-1/SIR-2.1/DAF-16 signaling axis, which upregulated downstream protective genes including catalases (ctl-1, ctl-2), superoxide dismutases (sod-1, sod-3), and the heat-shock protein hsp-16.2. Notably, 10 micromolar concentrations were toxic, underscoring a narrow therapeutic window.
These findings are significant because the JNK/SIRT1/FOXO pathway targeted by Vitamin K2 has conserved mammalian equivalents, suggesting the mechanism could translate to higher organisms. Vitamin K2 is already widely available as a supplement, making it an attractive candidate for further study.
However, important caveats apply. C. elegans lacks many mammalian organ systems, and the doses used do not directly translate to human equivalents. The study was conducted in a single model organism, and the summary here is based solely on the published abstract.
Key Findings
- 5 µM Vitamin K2 extended C. elegans lifespan; 10 µM was toxic — dose matters critically.
- Vitamin K2 reduced ROS, improved mitochondrial membrane potential, and boosted ATP production.
- Mechanism involves activation of the JNK-1/SIR-2.1/DAF-16 longevity signaling pathway.
- Downstream antioxidant genes (sod-1, sod-3, ctl-1, ctl-2) and heat-shock protein hsp-16.2 were upregulated.
- Vitamin K2 reduced lipofuscin accumulation, a hallmark biomarker of cellular aging.
Methodology
The study used C. elegans as a model organism, a standard system for aging research with well-characterized longevity pathways. Researchers tested multiple concentrations of Vitamin K2 and assessed lifespan, stress resistance, mitochondrial function, and gene expression. Genetic pathway involvement was confirmed through downstream target gene analysis.
Study Limitations
This study was conducted entirely in C. elegans, a simple invertebrate model that lacks many mammalian organ systems and metabolic complexity. Dose-to-human translation is not straightforward, and the longevity effects observed may not replicate in mammals. Additionally, this summary is based on the abstract only, as the full paper was not accessible.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.